This gene encodes a member of the SOX (SRY-related HMG-box) family of transcription factors involved in the regulation of embryonic development and in the determination of cell fate. The encoded protein may act as a transcriptional regulator after forming a protein complex with other proteins. It has also been determined to be a type-1 diabetes autoantigen, also known as islet cell antibody 12.[2]
In melanocytic cells SOX13 gene expression may be regulated by MITF.[3]
↑Hoek KS, Schlegel NC, Eichhoff OM, Widmer DS, Praetorius C, Einarsson SO, Valgeirsdottir S, Bergsteinsdottir K, Schepsky A, Dummer R, Steingrimsson E (Dec 2008). "Novel MITF targets identified using a two-step DNA microarray strategy". Pigment Cell & Melanoma Research. 21 (6): 665–76. doi:10.1111/j.1755-148X.2008.00505.x. PMID19067971.
Further reading
Wilson M, Koopman P (Aug 2002). "Matching SOX: partner proteins and co-factors of the SOX family of transcriptional regulators". Current Opinion in Genetics & Development. 12 (4): 441–6. doi:10.1016/S0959-437X(02)00323-4. PMID12100890.
Schepers GE, Teasdale RD, Koopman P (Aug 2002). "Twenty pairs of sox: extent, homology, and nomenclature of the mouse and human sox transcription factor gene families". Developmental Cell. 3 (2): 167–70. doi:10.1016/S1534-5807(02)00223-X. PMID12194848.
Argentaro A, Olsson J, Critcher R, McDowall SG, Harley VR (May 2000). "Genomic characterisation and fine mapping of the human SOX13 gene". Gene. 250 (1–2): 181–9. doi:10.1016/S0378-1119(00)00157-8. PMID10854791.
Kasimiotis H, Myers MA, Argentaro A, Mertin S, Fida S, Ferraro T, Olsson J, Rowley MJ, Harley VR (Apr 2000). "Sex-determining region Y-related protein SOX13 is a diabetes autoantigen expressed in pancreatic islets". Diabetes. 49 (4): 555–61. doi:10.2337/diabetes.49.4.555. PMID10871192.
Steinbrenner H, Lohmann T, Ostendorf B, Scherbaum WA, Seissler J (Nov 2000). "Autoantibodies to ICA12 (SOX-13) are not specific for Type I diabetes". Diabetologia. 43 (11): 1381–4. doi:10.1007/s001250051542. PMID11126406.
Kasimiotis H, Fida S, Rowley MJ, Mackay IR, Zimmet PZ, Gleason S, Rabin DU, Myers MA (2001). "Antibodies to SOX13 (ICA12) are associated with type 1 diabetes". Autoimmunity. 33 (2): 95–101. doi:10.3109/08916930108995994. PMID11264788.
Lampasona V, Scirpoli M, Bosi E, Bonifacio E (Feb 2001). "ICA12(SOX13) autoantibodies are unlikely to be a useful marker for pre-clinical Type I diabetes". Diabetologia. 44 (2): 267. doi:10.1007/s001250051610. PMID11270687.
Argentaro A, Wapelhorst B, Concannon P, Harley VR (Apr 2001). "Linkage studies of SOX13, the ICA12 autoantigen gene, in families with type 1 diabetes". Molecular Genetics and Metabolism. 72 (4): 356–9. doi:10.1006/mgme.2000.3136. PMID11286511.
Fida S, Myers M, Mackay IR, Zimmet PZ, Mohan V, Deepa R, Rowley MJ (Jun 2001). "Antibodies to diabetes-associated autoantigens in Indian patients with Type 1 diabetes: prevalence of anti-ICA512/IA2 and anti-SOX13". Diabetes Research and Clinical Practice. 52 (3): 205–11. doi:10.1016/S0168-8227(01)00230-3. PMID11323090.
Tandon N, Shtauvere-Brameus A, Hagopian WA, Sanjeevi CB (Apr 2002). "Prevalence of ICA-12 and other autoantibodies in north Indian patients with early-onset diabetes". Annals of the New York Academy of Sciences. 958: 214–7. doi:10.1111/j.1749-6632.2002.tb02972.x. PMID12021109.
Törn C, Shtauvere-Brameus A, Sanjeevi CB, Landin-Olsson M (Apr 2002). "Increased autoantibodies to SOX13 in Swedish patients with type 1 diabetes". Annals of the New York Academy of Sciences. 958: 218–23. doi:10.1111/j.1749-6632.2002.tb02973.x. PMID12021110.
Shtauvere-Brameus A, Hagopian W, Rumba I, Sanjeevi CB (Apr 2002). "Antibodies to new beta cell antigen ICA12 in Latvian diabetes patients". Annals of the New York Academy of Sciences. 958: 297–304. doi:10.1111/j.1749-6632.2002.tb02991.x. PMID12021128.
Gupta M, Tandon N, Shtauvere-Brameus A, Sanjeevi CB (Apr 2002). "ICA12 autoantibodies are associated with non-DR3/non-DR4 in patients with latent autoimmune diabetes in adults from northern India". Annals of the New York Academy of Sciences. 958: 329–32. doi:10.1111/j.1749-6632.2002.tb02998.x. PMID12021135.
Fida S, Myers MA, Whittingham S, Rowley MJ, Ozaki S, Mackay IR (Dec 2002). "Autoantibodies to the transcriptional factor SOX13 in primary biliary cirrhosis compared with other diseases". Journal of Autoimmunity. 19 (4): 251–7. doi:10.1006/jaut.2002.0622. PMID12473246.
Park Y, Park H, Yoo E, Kim D (Nov 2003). "SOX13 autoantibodies are likely to be a supplementary marker for type 1 diabetes in Korea". Annals of the New York Academy of Sciences. 1005: 253–8. doi:10.1196/annals.1288.038. PMID14679071.